ArticleNature cancer2023
Persister cell phenotypes contribute to poor patient outcomes after neoadjuvant chemotherapy in PDAC.
Xu Zhou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
45 papers cite it
this papertrialcites it
ArticleNature cancer2023
Xu Zhou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.